Page last updated: 2024-12-06

cryptating agent 222

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cryptating agent 222: forms ligands with metal cations; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72801
SCHEMBL ID27017
MeSH IDM0048142

Synonyms (57)

Synonym
4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8.]hexacosane
4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
nsc264495
cryptand 222
kryptofix 222
kryptofix merck 222
2,2-cryptand
cryptate 222
23978-09-8
cryptating agent 222
kriptofix 222
nsc-264495
4,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
crypt-2,2,2
einecs 245-962-4
cryptofix 222
brn 0620282
cryptand c 222
kryptand 222
4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo(8.8.8)hexacosane
nsc 264495
ligand 222
13,16,21,24-hexaoxa-1,10-diazabicyclo-(8,8,8)-hexacosane
4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane, 98%
H0932
cryptand 2.2.2
AKOS005463220
STK530369
A817018
4,7,13,16,21,24-hexaoxa-1,10-diazoniabicyclo[8.8.8]hexacosane;4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
18v22yhn6g ,
unii-18v22yhn6g
a-(222)
FT-0617280
AKOS015854436
kryptofix-222
BBL028994
SCHEMBL27017
2,2,2-cryptand
cryptand 222 [mi]
(2,2,2)crypand
cryptand-222
2,2,2-cryptate
2,2,2-crypt
c18h36n2o6
DTXSID00178697
mfcd00005111
J-015297
CS-W011776
SY010940
DS-5217
Q4596986
4,7,13,16,21,24-hexaoxa-1,10-diaza-bicyclo[8.8.8]hexacosane
A51055
AMY5255
[2.2.2]cryptand
4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo-[8.8.8]hexacosane
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (21.21)18.7374
1990's11 (33.33)18.2507
2000's6 (18.18)29.6817
2010's8 (24.24)24.3611
2020's1 (3.03)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.06 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]